New quadruple therapy for H. pylori infection
Part of Digestive system, Infections clinical trials.
This trial tests a combination of four medications to treat H. pylori, a bacteria that can cause stomach ulcers and other issues. The goal is to see if this newer therapy works well for people who are infected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with an H. pylori infection through a breath, stool, or stomach tissue test.
- You are willing to take medication to get rid of the H. pylori bacteria.
- Your medical records must include details of your treatment and follow-up tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how long (10 or 14 days) a combination of four medicines (bismuth quadruple therapy) should be taken to best treat H. pylori infection, and whether the best duration differs between women and men. It aims to find the shortest effective treatment to reduce side effects.
This trial tests if a newer acid-blocking medicine works better than a standard one when given with antibiotics and bismuth for treating H. pylori infection, a bacteria that can cause stomach ulcers. It is for adults who have not had treatment for H. pylori before.
This study is testing whether giving H. pylori treatment based on the specific bacteria found in your stomach works better than the standard one-size-fits-all approach. If you are already getting an endoscopy with a biopsy, this trial could help find the most effective medication for your infection.
This trial compares different lengths of treatment with two or four medications to see which works best for clearing H. pylori, a stomach bacteria that can cause ulcers. It is for people who have not been treated for this infection before.
This study tests a new combination of three medications (bismuth, tetracycline, and rabeprazole) to see if it can successfully get rid of H. pylori infection on the first try. The goal is to offer a simpler and effective treatment option for people who haven't been treated for H. pylori before.
This study compares two treatment plans for H. pylori infection (a stomach bacteria). It looks at whether a 3-drug combination works as well as a 4-drug combination to clear the infection.
Hear when a new Helicobacter Pylori Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.